Validating the EQ-5D with time trade off for the German population W Greiner, C Claes, JJV Busschbach, JM Graf von der Schulenburg The European journal of health economics 6 (2), 124-130, 2005 | 406 | 2005 |
The influence of economic evaluation studies on decision making.: a European survey C Hoffmann, JMG von der Schulenburg Health policy 52 (3), 179-192, 2000 | 232 | 2000 |
Measuring economic consequences of preterm birth-Methodological recommendations for the evaluation of personal burden on children and their caregivers JM Hodek, J Von der Schulenburg, T Mittendorf Health economics review 1 (1), 1-10, 2011 | 195 | 2011 |
Die deutsche version des EuroQol-Fragebogens JM Graf, C Claes, W Greiner, A Uber Zeitschrift für Gesundheitswissenschaften= Journal of public health 6 (1), 3-20, 1998 | 174 | 1998 |
German value set for the EQ-5D-5L K Ludwig, J Graf von der Schulenburg, W Greiner Pharmacoeconomics 36 (6), 663-674, 2018 | 164 | 2018 |
Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting K Schmidt, I Aumann, I Hollander, K Damm, J Von Der Schulenburg, ... BMC medical informatics and decision making 15 (1), 1-27, 2015 | 148 | 2015 |
Consumer information and decisions to switch insurers H Schlesinger, JMG von der Schulenburg Journal of Risk and Insurance, 591-615, 1993 | 147 | 1993 |
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus JM Graf von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, ... Value in health 11 (4), 539-544, 2008 | 144 | 2008 |
Search costs, switching costs and product heterogeneity in an insurance market H Schlesinger, JMG Von der Schulenburg Journal of Risk and Insurance, 109-119, 1991 | 140 | 1991 |
Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation-dritte und aktualisierte Fassung des Hannoveraner Konsens JMG von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, R Leidl, ... Gesundheitsökonomie & Qualitätsmanagement 12 (05), 285-290, 2007 | 135 | 2007 |
Gesundheitsökonomik JM Von der Schulenburg, W Greiner Mohr Siebeck, 2007 | 131 | 2007 |
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources J Ruof, JL Hülsemann, T Mittendorf, S Handelmann, ... Annals of the rheumatic diseases 62 (6), 544-549, 2003 | 119 | 2003 |
Cost of care and clinical condition in paediatric cystic fibrosis patients U Baumann, C Stocklossa, W Greiner, JMG von der Schulenburg, ... Journal of Cystic Fibrosis 2 (2), 84-90, 2003 | 100 | 2003 |
Cost of poor adherence to anti-hypertensive therapy in five European countries FS Mennini, A Marcellusi, JM von der Schulenburg, A Gray, P Lévy, ... The European journal of health economics 16 (1), 65-72, 2015 | 78 | 2015 |
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare B Jönsson, G Hampson, J Michaels, A Towse, J von der Schulenburg, ... The European Journal of Health Economics 20 (3), 427-438, 2019 | 76 | 2019 |
Risikoethik J Nida-Rümelin, J Schulenburg, B Rath Risikoethik, 2012 | 74 | 2012 |
A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer A Lange, A Prenzler, M Frank, M Kirstein, A Vogel, ... European journal of cancer 50 (1), 40-49, 2014 | 73 | 2014 |
Stereotactic radiosurgery for the treatment of brain metastases F Müller-Riemenschneider, A Bockelbrink, I Ernst, C Schwarzbach, ... Radiotherapy and Oncology 91 (1), 67-74, 2009 | 73 | 2009 |
Medical effectiveness and safety of conventional compared to laparoscopic incisional hernia repair: a systematic review F Müller-Riemenschneider, S Roll, M Friedrich, J Zieren, T Reinhold, ... Surgical endoscopy 21 (12), 2127-2136, 2007 | 68 | 2007 |
Diffusion of innovations: treatment of Alzheimer's disease in Germany J Ruof, T Mittendorf, O Pirk, JMG von der Schulenburg Health Policy 60 (1), 59-66, 2002 | 62 | 2002 |